Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
作者： Micheal L. Gruenberg
DOI:
关键词:
摘要: Compositions containing clinically relevant numbers of immune cells that have been isolated from a patient differentiated and/or expanded ex vivo. Methods for treating or preventing disease otherwise altering the status by reinfusing such into donor are also provided. expanding cells, including effector in absence exogenous IL-2, and administering co-infused IL-2
glgoo.top参考文章(79)
Allen S. Reichler, Scott T. Waniger, Bruce P. Amiot, Martin H. Banas, Process for improving mass transfer in a membrane bioreactor and providing a more homogeneous culture environment ,(1990)
Bernard Besnainon, Alain Philippe, Pierre Lessart, Marie-Paule Elluard, Mineral hollow fiber bioreactor for the cultivation of animal cells ,(1989)
Terry L. Bowlin, Sai P. Sunkara, Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor ,(1989)
Uday K. Veeramallu, Timothy C. Gebhard, Hollow fiber cell propagation system and method ,(1990)
Carina Henningsson, B. Michael Longenecker, Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype ,(1988)
James R. Robinson, Method and apparatus for culturing and diffusively oxygenating cells on isotropic membranes ,(1988)
Francis Brasseur, Thierry Boon-Falleur, Jean-Jacques Patard, Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 ,(1994)
Barbara Alter, Augusto C. Ochoa, Paul Sondel, Fritz H. Bach, Method of culturing lymphocytes and method of treatment using such lymphocytes ,(1988)